Evaxion A/S American Depositary Share (EVAX) is a publicly traded Healthcare sector company. As of May 21, 2026, EVAX trades at $3.79 with a market cap of $34.11M and a P/E ratio of 0.00. EVAX moved +0.00% today. Year to date, EVAX is -16.67%; over the trailing twelve months it is +128.57%. Its 52-week range spans $1.20 to $16.10. Analyst consensus is strong buy with an average price target of $11.25. Rallies surfaces EVAX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge funds tracked by Rallies that own EVAX include Citadel Advisors. The latest tracked quarter is Sep 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Evaxion A/S American Depositary Share.
| Metric | Value |
|---|---|
| Price | $3.79 |
| Market Cap | $34.11M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $16.10 |
| 52-Week Low | $1.20 |
| Volume | 25 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
4 analysts cover EVAX: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $11.25.